Germany · Delayed Price · Currency is EUR Symrise AG Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw a slight organic sales decline but outperformed expectations, with strong growth in key segments and regions offsetting EMEA and Scent & Care weakness. Full-year guidance is reaffirmed, with sequential improvement and margin expansion expected.
Fiscal Year 2025
-
2025 saw resilient organic growth, record profitability, and strong cash flow despite FX and market headwinds. Strategic transformation, portfolio optimization, and efficiency gains drove margin expansion, while 2026 guidance remains prudent amid macro uncertainty, with growth expected to accelerate in H2.
-
Q3 2025 saw 1.4% organic sales growth, with strong performance in EMEA and food & beverage, but softness in North America and Latin America. Full-year growth guidance was lowered to 2.3%-3.3% amid macro headwinds, while cost savings and margin targets remain on track.
-
Solid H1 2025 results with 3.1% organic sales growth, 12% net income increase, and improved margins driven by efficiency gains and cost savings. Guidance for full-year organic growth was moderated to 2%-5%, but margin and cash flow targets were raised, reflecting confidence in ongoing transformation.
-
Double-digit organic growth in beverages and strong performance in APAC and EAME drove industry-leading results, while Scent & Care and Aroma Molecules posted high single-digit growth. Guidance for 2025 and 2028 was reaffirmed, with ongoing innovation, efficiency initiatives, and strategic portfolio management supporting future growth.
Fiscal Year 2024
-
Organic growth reached 8.7% in 2024, with EBITDA surpassing €1 billion and net income up 40% year-over-year. Both main segments and all regions contributed, and 2025 guidance targets 5%-7% organic growth and a 21% EBITDA margin.
-
Group sales rose 11.1% organically in the first nine months, driven by strong volume growth in both segments, but hyperinflation effects—mainly from Argentina—will create a Q4 headwind, leading to a full-year organic sales growth guidance of around 7% excluding hyperinflation.
-
Strong H1 2024 results with 11.5% organic sales growth, improved margins, and robust cash flow. Guidance for 2024 is reaffirmed, with disciplined CapEx and continued efficiency gains supporting long-term targets.